Danaher Corporation DHR recently partnered with AstraZeneca PLC AZN to develop and market novel diagnostic tools aimed at ...

Sortera Bio, a Cambridge biotech based on IP developed at the MRC Laboratory of Molecular Biology, has attracted big hitting ...

The government said a “change in the make-up of the investment” proposed by AstraZeneca, which is headquartered in Cambridge, England, had led to a change in the grant it was willing to offer.

AstraZeneca is based in five different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,700 employees work in research and development, manufacturing ...

AstraZeneca Plc will invest £650 million ($827 million) into Britain, expanding its Cambridge base and building a vaccine manufacturing plant near Liverpool. The drug-maker, which partnered with ...

AstraZeneca announced the new facility in March as part of wider plans to invest £650m across the UK. This would be split into £450m for the Speke project and a further £200m for Cambridge ...

The firm is already well under way in its plans to unify global commercial operations and R&D in England's science hotspot, Cambridge, from 2016. AstraZeneca sees a bright future in its new global ...